Literature DB >> 21882900

MCF-7 cells as a three-dimensional model for the study of human breast cancer.

Jônatas Bussador do Amaral1, Paula Rezende-Teixeira, Vanessa Morais Freitas, Gláucia Maria Machado-Santelli.   

Abstract

The increasing use of three-dimensional (3D) cell culture is because it reproduces in vitro results similar to in vivo results. Multicellular tumor spheroids generated in vitro exhibit important characteristics of avascular tumors, mainly with respect to tumor physiology and microenvironment. The interaction among cells in a tridimensional culture environment enhances cell differentiation and leads to luminal formation in some breast-derived cell cultures. The present work describes a method that permits luminal formation in breast adenocarcinoma cell (MCF-7)-derived spheroids in a 3D environment. In the proposed model, several relevant parameters, such as cell survival, apoptosis, autophagy, and E-cadherin expression, were analyzed to understand the organization of MCF-7 cells during different culture phases, including luminal and bud formation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21882900     DOI: 10.1089/ten.tec.2011.0260

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  16 in total

1.  Three-dimensional microenvironment confers enhanced sensitivity to doxorubicin by reducing p53-dependent induction of autophagy.

Authors:  L R Gomes; A T Vessoni; C F M Menck
Journal:  Oncogene       Date:  2015-01-26       Impact factor: 9.867

2.  FILIP1L Loss Is a Driver of Aggressive Mucinous Colorectal Adenocarcinoma and Mediates Cytokinesis Defects through PFDN1.

Authors:  Mijung Kwon; Genesaret Rubio; Nicholas Nolan; Peter Auteri; Jean Arly Volmar; Asha Adem; Parisa Javidian; Zhongren Zhou; Michael P Verzi; Sharon R Pine; Steven K Libutti
Journal:  Cancer Res       Date:  2021-08-20       Impact factor: 12.701

3.  A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents.

Authors:  Sylvia Herter; Laura Morra; Ramona Schlenker; Jitka Sulcova; Linda Fahrni; Inja Waldhauer; Steffi Lehmann; Timo Reisländer; Irina Agarkova; Jens M Kelm; Christian Klein; Pablo Umana; Marina Bacac
Journal:  Cancer Immunol Immunother       Date:  2016-11-17       Impact factor: 6.968

4.  Keep it on the edge: The post-mitotic midbody as a polarity signal unit.

Authors:  Pablo Lujan; Teresa Rubio; Giulia Varsano; Maja Köhn
Journal:  Commun Integr Biol       Date:  2017-07-05

5.  Human neuroendocrine tumor cell lines as a three-dimensional model for the study of human neuroendocrine tumor therapy.

Authors:  Chung Wong; Evan Vosburgh; Arnold J Levine; Lei Cong; Eugenia Y Xu
Journal:  J Vis Exp       Date:  2012-08-14       Impact factor: 1.355

6.  MCF-7 Human Breast Cancer Cells Form Differentiated Microtissues in Scaffold-Free Hydrogels.

Authors:  Marguerite M Vantangoli; Samantha J Madnick; Susan M Huse; Paula Weston; Kim Boekelheide
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

7.  A 3D fibrous scaffold inducing tumoroids: a platform for anticancer drug development.

Authors:  Yvonne K Girard; Chunyan Wang; Sowndharya Ravi; Mark C Howell; Jaya Mallela; Mahmoud Alibrahim; Ryan Green; Gary Hellermann; Shyam S Mohapatra; Subhra Mohapatra
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

Review 8.  The multiple facets of drug resistance: one history, different approaches.

Authors:  Evandro Luís Niero; Bianca Rocha-Sales; Camila Lauand; Beatriz Araujo Cortez; Marcelo Medina de Souza; Paula Rezende-Teixeira; Marcel Shiniti Urabayashi; Adam Arai Martens; Jorge Henrique Neves; Gláucia Maria Machado-Santelli
Journal:  J Exp Clin Cancer Res       Date:  2014-04-28

9.  Autophagy initiation correlates with the autophagic flux in 3D models of mesothelioma and with patient outcome.

Authors:  Carlo Follo; Dario Barbone; William G Richards; Raphael Bueno; V Courtney Broaddus
Journal:  Autophagy       Date:  2016-04-20       Impact factor: 16.016

10.  PRL-3 disrupts epithelial architecture by altering the post-mitotic midbody position.

Authors:  Pablo Luján; Giulia Varsano; Teresa Rubio; Marco L Hennrich; Timo Sachsenheimer; Manuel Gálvez-Santisteban; Fernando Martín-Belmonte; Anne-Claude Gavin; Britta Brügger; Maja Köhn
Journal:  J Cell Sci       Date:  2016-09-21       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.